EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 3, 2020
Media advisory: The full study and related articles are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0734?guestAccessKey=b8611590-4ce2-40fa-bb85-27b742efd4e9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030320
What The Study Did: A variety of data were used to estimate annual health care spending in the U.S. from 1996 through 2016 by payer (public insurance, private insurance and out-of-pocket payments) and by health conditions, including low back pain and musculoskeletal disorders, diabetes and ischemic heart disease. This study is part of a theme issue from JAMA on drug pricing.
Authors: Joseph L. Dieleman, Ph.D., of the Institute for Health Metrics and Evaluation in Seattle, is the corresponding author.
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.